1. Home
  2. DK vs ELVN Comparison

DK vs ELVN Comparison

Compare DK & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delek US Holdings Inc.

DK

Delek US Holdings Inc.

HOLD

Current Price

$40.32

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Logo Enliven Therapeutics Inc.

ELVN

Enliven Therapeutics Inc.

HOLD

Current Price

$43.29

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DK
ELVN
Founded
2001
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.3B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
DK
ELVN
Price
$40.32
$43.29
Analyst Decision
Hold
Strong Buy
Analyst Count
17
5
Target Price
$38.88
$43.40
AVG Volume (30 Days)
1.1M
1.3M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
2.56%
N/A
EPS Growth
95.67
3.17
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.85
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.80
$14.79
52 Week High
$48.32
$48.53

Technical Indicators

Market Signals
Indicator
DK
ELVN
Relative Strength Index (RSI) 47.68 58.43
Support Level $36.34 $16.84
Resistance Level $40.55 $48.53
Average True Range (ATR) 1.97 2.42
MACD -0.43 -0.50
Stochastic Oscillator 35.05 47.59

Price Performance

Historical Comparison
DK
ELVN

About DK Delek US Holdings Inc.

Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has three segments: Refining segment and Logistics segment and retail segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

Share on Social Networks: